Dual neutralization of IL-17A and IL-17F with bimekizumab improves quality of life in patients withmoderate-to-severe plaque psoriasis: results from a Phase 2b study and correlation with clinical response

Main Article Content

Kim A Papp
Joseph F Merola
Alice B Gottlieb
Et al.

Keywords

Abstract

Abstract not available.

 

Disclosures: Study sponsored by UCB Pharma.

Copyright 2018 SKIN